Intraventricular teicoplanin

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Following craniotomy for an atypical rhabdoid tumour of the posterior cranial fossa, a fourteen-month-old boy developed a ventriculitis with methicillin resistant Staphylococcus epidermidis (MRSE) which is associated with the use of a ventriculoperitoneal shunt. Treatment with intravenous vancomycin resulted in a severe allergic skin reaction. Substitution with intravenous teicoplanin resulted in negative blood culture and MRSE ventriculitis was successfully eradicated with concomitant use of intraventricular teicoplanin. No signs of recurrent infection or adverse events occurred. Intraventricular teicoplanin is safe and effective for the treatment of staphylococcal neurosurgical shunt infections. (JUMMEC 2009; 12(1):35-38).

Cite

CITATION STYLE

APA

Shanti, R., Sam, I. C., & Ariffin, H. (2009). Intraventricular teicoplanin. Journal of Health and Translational Medicine, 12(1), 35–38. https://doi.org/10.22452/jummec.vol12no1.7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free